Craig W. Philips, Mba

Biography

Mr. Philips has over 25 years of pharmaceutical experience in the US and overseas with large, intermediate and start-up companies. His extensive career includes experience with development and commercialization of both small molecules and biologic agents in a variety of sectors including: oncology, autoimmune diseases, cardiovascular disorders, viral diseases, dermatology and others. He spent the early part of his career with Bristol Myers and held senior positions at both Schering Plough (now Merck), and Bayer Schering Pharmaceuticals. He was President at Cell Therapeutics, a company focused on new cancer therapies. In 2012 he accepted an invitation to serve as Entrepreneur-in-Residence at the University of Washington. He works with staff and faculty to advance the spinout and licensing of life science and emerging technology platforms. Mr. Philips has broad industry experience and an extensive record in lifecycle management, commercialization of new drugs, and business development and partnership management. He received a BSBA and MBA from Ohio State University. He has been actively involved in pharmaceutical industry organizations in the US and overseas and served as a board member to the leading industry organizations in Canada, Thailand and Australia.

Research Interest

Mr. Philips has over 25 years of pharmaceutical experience in the US and overseas with large, intermediate and start-up companies. His extensive career includes experience with development and commercialization of both small molecules and biologic agents in a variety of sectors including: oncology, autoimmune diseases, cardiovascular disorders, viral diseases, dermatology and others. He spent the early part of his career with Bristol Myers and held senior positions at both Schering Plough (now Merck), and Bayer Schering Pharmaceuticals. He was President at Cell Therapeutics, a company focused on new cancer therapies. In 2012 he accepted an invitation to serve as Entrepreneur-in-Residence at the University of Washington. He works with staff and faculty to advance the spinout and licensing of life science and emerging technology platforms. Mr. Philips has broad industry experience and an extensive record in lifecycle management, commercialization of new drugs, and business development and partnership management. He received a BSBA and MBA from Ohio State University. He has been actively involved in pharmaceutical industry organizations in the US and overseas and served as a board member to the leading industry organizations in Canada, Thailand and Australia.